Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Dapsone
Active Ingredient: Dapsone 100mg
Dosage Form: Tablet
New Zealand Sponsor: Link Pharmaceuticals Limited
Manufacturer: Jacobus Pharmaceutical Company Inc, Plainsboro, New Jersey, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Dapsone
Active Ingredient: Dapsone 25mg
Dosage Form: Tablet
New Zealand Sponsor: Link Pharmaceuticals Limited
Manufacturer: Jacobus Pharmaceutical Company Inc, Plainsboro, New Jersey, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 14th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).